Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-13 5:18 pm Purchase | 13G | GlycoMimetics, Inc. GLYC | Artal International S.C.A. | 6,573,798 12.5% | 6,573,798 (New Position) | View |
| 2023-02-10 7:56 pm Purchase | 13G | Morphic Holding, Inc. MORF | Artal International S.C.A. | 2,150,000 5.6% | 564,951 (+35.64%) | View |
| 2023-02-10 7:53 pm Purchase | 13G | SQZ Biotechnologies Company SQZ | Artal International S.C.A. | 1,606,309 5.5% | 1,606,309 (New Position) | View |
| 2023-02-10 7:41 pm Sale | 13G | Syros Pharmaceuticals, Inc. SYRS | Artal International S.C.A. | 1,463,829 7.2% | -2,036,171 (-58.18%) | View |
| 2023-02-10 7:36 pm Sale | 13G | Vigil Neuroscience, Inc. VIGL | Artal International S.C.A. | 2,243,352 6.3% | -42,222 (-1.85%) | View |
| 2023-02-10 7:34 pm Sale | 13G | Omega Alpha SPAC OMEG | Artal International S.C.A. | 0 0% | -750,000 (Position Closed) | View |
| 2023-02-10 7:33 pm Purchase | 13G | Scholar Rock Holding Corporation SRRK | Artal International S.C.A. | 10,555,278 19.8% | 230,236 (+2.23%) | View |
| 2023-02-10 7:31 pm Unchanged | 13G | NexImmune, Inc. NEXI | Artal International S.C.A. | 1,200,000 4.6% | 0 (Unchanged) | View |
| 2023-02-10 7:28 pm Purchase | 13G | IGM Biosciences, Inc. IGMS | Artal International S.C.A. | 2,450,000 8.4% | 950,000 (+63.33%) | View |
| 2023-02-10 7:28 pm Purchase | 13G | Aravive, Inc. ARAV | Artal International S.C.A. | 12,182,037 9.9% | 10,870,746 (+829.01%) | View |
| 2023-02-10 7:25 pm Sale | 13G | BELLUS Health Inc. BLU | Artal International S.C.A. | 3,700,000 2.9% | -4,800,000 (-56.47%) | View |
| 2023-02-10 7:21 pm Unchanged | 13G | Aptinyx Inc. APTX | Artal International S.C.A. | 6,116,493 9% | 0 (Unchanged) | View |
| 2023-02-10 7:21 pm Unchanged | 13G | Ambrx Biopharma Inc. AMAM | Artal International S.C.A. | 15,066,043 5.6% | 0 (Unchanged) | View |
| 2023-02-10 7:15 pm Unchanged | 13G | Achilles Therapeutics plc ACHL | Artal International S.C.A. | 2,255,375 5.5% | 0 (Unchanged) | View |
| 2023-02-01 4:30 pm Purchase | 13G | Agenus Inc. AGEN | Artal International S.C.A. | 15,631,235 5.1% | 15,631,235 (New Position) | View |
| 2022-08-23 4:16 pm Purchase | 13G | Vigil Neuroscience, Inc. VIGL | Artal International S.C.A. | 2,285,574 6.4% | 2,285,574 (New Position) | View |
| 2022-08-05 4:31 pm Purchase | 13G | AlloVir, Inc. ALVR | Artal International S.C.A. | 5,577,167 6% | 5,577,167 (New Position) | View |
| 2022-06-24 4:20 pm Purchase | 13G | Scholar Rock Holding Corporation SRRK | Artal International S.C.A. | 10,325,042 19.4% | 7,875,042 (+321.43%) | View |
| 2022-02-11 06:47 am Sale | 13G | Seer, Inc. SEER | Artal International S.C.A. | 4,750,000 8.3% | -1,090,911 (-18.68%) | View |
| 2022-02-11 06:40 am Purchase | 13G | BELLUS Health Inc. BLU | Artal International S.C.A. | 8,500,000 8.2% | 3,750,000 (+78.95%) | View |